文献速递小儿骨科骨质疏松与代谢性骨病

探索杜氏肌营养不良症骨密度的自然史:一项系统性文献综述

Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review.
PubMed 文献 · Osteoporos Int · 2025-08-29

该系统综述检索2000至2023年PubMed与Embase文献,评估接受糖皮质激素治疗的5-15岁杜氏肌营养不良症患者骨密度自然进程。腰椎面积骨密度Z评分随年龄和糖皮质激素使用时间下降,腰椎面积骨密度Z评分每降低1个标准差,骨折个体百分比增加21%。

要点

  • 腰椎面积骨密度Z评分随年龄下降-0.25 SDS/年(p<0.001,n=1527)。
  • 腰椎面积骨密度Z评分随糖皮质激素使用时间延长下降-0.24 SDS/年(p<0.001,n=817)。
  • 腰椎面积骨密度Z评分每降低1 SDS,骨折个体百分比增加21%(p<0.01,n=1066)。

核心结论

  • 了解骨密度自然史及与骨脆性相关的疾病进展有助于支持临床试验设计,以评估和改善杜氏肌营养不良症的骨强度。
  • 据作者所知,这是首个研究接受糖皮质激素治疗的杜氏肌营养不良症个体骨密度Z评分轨迹的系统综述,并强调年龄和糖皮质激素治疗时长与腰椎面积骨密度、全身除头及股骨远端外侧Z评分下降的关联。

研究设计与样本

  • 系统性文献综述,检索PubMed与Embase中2000年至2023年发表的同行评议文章,聚焦接受糖皮质激素治疗的5-15岁杜氏肌营养不良症患者。
  • 统计分析先进行相关性分析,后采用广义线性混合模型研究骨健康生物标志物与临床因素的关系。

主要发现

  • 腰椎面积骨密度Z评分随年龄下降-0.25 SDS/年(p<0.001,n=1527),随糖皮质激素使用时间延长下降-0.24 SDS/年(p<0.001,n=817)。
  • 全身除头骨密度Z评分随年龄下降-0.26 SDS/年,股骨远端外侧骨密度Z评分随年龄下降-0.41 SDS/年。
  • 腰椎面积骨密度Z评分每降低1 SDS,骨折个体百分比增加21%(p<0.01,n=1066)。
  • 腰椎面积骨密度Z评分下降在11岁后显著加速,年龄较大者较年龄较小者下降更快。

关键数值与推荐

  • 腰椎面积骨密度Z评分随年龄变化:-0.25 SDS/年(p<0.001,n=1527)。
  • 腰椎面积骨密度Z评分随糖皮质激素使用时间变化:-0.24 SDS/年(p<0.001,n=817)。
  • 全身除头骨密度Z评分随年龄变化:-0.26 SDS/年。
  • 股骨远端外侧骨密度Z评分随年龄变化:-0.41 SDS/年。
  • 腰椎面积骨密度Z评分每降低1 SDS,骨折个体百分比增加21%(p<0.01,n=1066)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In Duchenne muscular dystrophy (DMD) osteoporosis and fragility fractures present significant comorbidities, resulting from progressive myopathy reduced weight-bearing and osteotoxic effects of prolonged glucocorticoid (GC) use. This systematic literature review (SLR) assessed the natural course of bone mineral density (BMD) in individuals with DMD and the factors associated with its natural progression. METHODS: A systematic literature review was conducted to evaluate BMD in individuals with DMD. Searches were performed in PubMed® and Embase® for peer-reviewed articles published between 2000 and 2023, focusing on DMD patients aged 5-15 years receiving GC treatment. Statistical analyses employed an initial correlation analyses followed by generalized linear mixed models (GLMMs) to investigate relationships between bone health biomarkers and clinical factors. RESULTS: Strong associations were observed between lumbar spine (LS) BMD Z-scores, age and GC treatment duration. LS areal BMD (aBMD) Z-scores declined with age (-0.25 SDS/year, p < 0.001, n = 1527) and with longer GC use (-0.24 SDS/year, p < 0.001, n = 817). Total body less head (TBLH) and lateral distal femur (LDF) BMD Z-scores also decreased with age at a rate of -0.26 SDS/year and - 0.41 SDS/year, respectively. The percentage of individuals with fractures increased by 21% (p < 0.01, n = 1066) for every 1-SDS decrease in LS aBMD Z-score. Reductions in LS aBMD Z-scores significantly accelerated after 11 years of age, with older versus younger individuals experiencing a faster decline. CONCLUSION: Understanding the natural history of BMD and disease progression relating to bone fragility will help to support clinical trial design to assess and improve bone strength in DMD. To our knowledge, this is the first SLR investigating BMD Z-score trajectories in individuals with DMD receiving GCs and highlights associations between age and GC treatment duration with declining LS aBMD, TBLH, and LDF Z-scores.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. De Ford C, Guridi M, Chen Y, et al. Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review. Osteoporos Int. 2025. PMID: 40879743. doi:10.1007/s00198-025-07651-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。